How Does Orlistat Work in the Body

Chemical Composition, Mechanism of Action & Metabolic Effects Explained

Key Takeaways: How Orlistat Works

  • Primary Action: Inhibits gastric and pancreatic lipases in the gut
  • Chemical Effect: Blocks breakdown of dietary triglycerides into absorbable free fatty acids
  • Physiological Result: About one‑third of ingested fat is not digested and passes out in stools
  • Systemic Exposure: Orlistat is minimally absorbed (<1%) and acts locally in the gastrointestinal tract
  • Weight Loss: Enhances weight loss when combined with a reduced‑calorie diet
  • Fat Soluble Vitamins: May reduce absorption of vitamins A, D, E, K – supplement advised

Orlistat is a prescription weight‑loss medication that works locally in your gut to prevent about one‑third of the fat you eat from being absorbed. Instead of entering your bloodstream, the undigested fat is eliminated naturally.

Important Medical Advice

If you experience severe abdominal pain, persistent oily rectal discharge, signs of allergic reaction (rash, itching, swelling, difficulty breathing), or symptoms of pancreatitis (severe upper stomach pain spreading to back), seek medical attention immediately.

Chemical Composition & Molecular Structure of Orlistat

Orlistat chemical structure diagram

Orlistat is a chemically synthesised derivative of lipstatin, a natural product from the bacterium Streptomyces toxytricini. Its molecular design allows it to fit snugly into the active site of lipase enzymes.

Chemical Structure Details

Chemical Name

(S)-2-formylamino-4-methyl-pentanoic acid (S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]-dodecyl ester

This complex ester enables orlistat to covalently bind to the serine residue of lipases, causing irreversible inhibition.

Molecular Formula

C29H53NO5

29 carbon, 53 hydrogen, 1 nitrogen, and 5 oxygen atoms.

Molecular Weight

495.7 g/mol

Relatively large molecule that remains in the gut lumen due to minimal absorption.

Key Pharmaceutical Properties

PropertyValue/CharacteristicClinical Significance
SolubilityPractically insoluble in water; soluble in ethanolRemains in GI tract, minimal systemic absorption
LipophilicityHigh (log P ~8.5)Enables binding to lipase enzymes at the lipid‑water interface
Protein Binding>99% (in plasma, but irrelevant as drug is minimally absorbed)Negligible systemic drug interactions
Mechanism of InhibitionIrreversible, covalent binding to serine residue of lipasesLong duration of action within the gut (about 24h enzyme turnover)

🗒️ Pharmaceutical Insight: Orlistat’s β‑lactone ring opens to form a covalent bond with the serine hydroxyl group in the active site of gastric and pancreatic lipases. This irreversible inhibition means the enzyme is permanently inactivated and must be replaced by newly synthesised enzyme.

Mechanism of Action: How Orlistat Prevents Fat Absorption

Orlistat works by directly inhibiting the enzymes responsible for breaking down dietary fat. Here’s the step‑by‑step process:

Normal Fat Digestion

  1. Ingestion: Dietary triglycerides enter the stomach.
  2. Emulsification: Gastric motility and bile salts emulsify fat into small droplets.
  3. Lipase Action: Gastric lipase (stomach) and pancreatic lipase (small intestine) hydrolyse triglycerides into free fatty acids and monoglycerides.
  4. Absorption: These breakdown products are absorbed by intestinal cells and packaged into chylomicrons.

Orlistat’s Intervention

StepNormal ProcessOrlistat Effect
1. Fat ingestionTriglycerides enter duodenumNo change – drug must be present with meal
2. Lipase secretionPancreatic lipase released into intestineOrlistat binds covalently to lipase’s active site
3. Fat hydrolysisLipase breaks triglycerides into absorbable fatty acidsLipase is inactivated → triglycerides remain intact
4. AbsorptionFatty acids absorbed into bloodstreamUndigested fat cannot be absorbed → excreted in faeces

🗒️ Physiological Insight: Orlistat typically blocks the digestion of about 30% of dietary fat. This undigested fat is responsible for the characteristic gastrointestinal effects (oily stools, spotting) that remind patients to stick to a low‑fat diet.

Enzyme Inhibition: Targeting Gastric and Pancreatic Lipases

Orlistat is a highly selective, irreversible inhibitor of lipases – enzymes that hydrolyse dietary fat.

Inhibition Characteristics

Inhibition Type

Irreversible covalent inhibition

The β‑lactone ring opens and forms a stable ester with the active‑site serine.

Enzyme Targets

Gastric lipase, pancreatic lipase, carboxyl ester lipase

Also inhibits bile‑salt‑stimulated lipase.

Selectivity

>1000‑fold more potent against lipases than other serine hydrolases

Minimal effect on other digestive enzymes (amylase, proteases).

Potency and Duration

ParameterValueClinical Meaning
IC50 against pancreatic lipase~50 ng/mLVery potent inhibition at low concentrations
Duration of inhibitionEnzyme turnover time (~24 hours)Once bound, enzyme is permanently inactivated – new enzyme must be synthesised
Recovery of lipase activity24‑48 hours after last doseNormal fat digestion returns within 2 days

🗒️ Biochemical Insight: Because orlistat inactivates lipases permanently, its effect lasts long after the drug has been cleared from the gut. This is why taking it with each fat‑containing meal provides continuous coverage.

Metabolic Effects: What Happens to Orlistat in the Body

Orlistat is designed to work locally – it is minimally absorbed and undergoes very little metabolism.

Metabolic Pathway

Absorption

Systemic bioavailability:<1% of an oral dose

Peak plasma levels: Extremely low (around 0.2 ng/mL after 120mg dose)

Metabolism

Primary metabolites: Two main metabolites – M1 (4‑membered lactone ring hydrolysed) and M3 (M1 with cleaved N‑formyl group)

Metabolising enzymes: Minimal; most drug excreted unchanged

Elimination

Route: ~97% excreted in faeces (83% as unchanged orlistat)

Renal excretion:<2% of the tiny absorbed fraction

Timeline of Effects After a 120mg Dose

  1. 0‑1 hour: Orlistat mixes with food in stomach and small intestine, binds to lipases.
  2. 1‑6 hours: Maximal enzyme inhibition; dietary fat remains undigested.
  3. 6‑24 hours: Gradual excretion of orlistat in faeces; lipase activity slowly recovers as new enzymes are synthesised.
  4. 24‑48 hours: Normal fat digestion returns if no further doses taken.

🗒️ Clinical Correlation: Because orlistat is not absorbed, systemic side effects are rare. However, fat‑soluble vitamin levels may fall with long‑term use – a daily multivitamin (taken at least 2 hours apart from orlistat) is recommended.

Absorption, Distribution & Elimination of Orlistat

Understanding the pharmacokinetics helps explain why orlistat is so safe and how to use it effectively.

Pharmacokinetic Profile

Absorption

Bioavailability:<1% – negligible systemic exposure

Effect of food: Taken with meals to ensure mixing with dietary fat

Distribution

Volume of distribution: Not applicable (minimally absorbed)

Protein binding: >99% (but irrelevant due to low plasma levels)

Elimination

Half‑life: 14‑19 hours (based on faecal excretion)

Faecal excretion: 97% of dose (83% unchanged, 4% as metabolites)

Special Population Considerations

PopulationEffect on OrlistatDosing Consideration
Elderly (≥65 years)No significant differenceStandard dose (120mg three times daily) is appropriate
Renal impairmentMinimal systemic exposure – no adjustment neededCan be used with caution
Hepatic impairmentNot studied, but systemic exposure is negligibleLikely safe, but monitor vitamin levels
Drug interactionsMay reduce absorption of ciclosporin, amiodarone, some antiepilepticsSeparate dosing by at least 3‑4 hours; monitor levels

🗒️ Clinical Warning: Although orlistat itself is not absorbed, it can impair absorption of other drugs (e.g., ciclosporin, levothyroxine). Always take other medications at least 2 hours apart from orlistat.

Clinical Efficacy for Weight Loss

Orlistat’s unique mechanism translates into proven, modest weight loss when combined with lifestyle changes.

Efficacy Data from Clinical Studies

Study / PopulationWeight Loss with Orlistat + DietPlacebo + Diet
1‑year randomised trial (n=675)8.8 kg (9.6% of body weight)5.8 kg (6.5%)
2‑year extension studyMaintained 7.6 kg lossRegained most weight
Patients with type 2 diabetes6.2 kg loss + improved HbA1c3.8 kg loss

Optimal Use Guidelines Based on Mechanism

  1. Take with each main meal containing fat: The capsule must be present when fat enters the gut.
  2. Follow a low‑fat diet (≤30% calories from fat): Reduces gastrointestinal side effects and improves tolerability.
  3. Skip dose if meal contains no fat: No fat → no need for lipase inhibition.
  4. Take a daily multivitamin: At bedtime, at least 2 hours after last orlistat dose, to compensate for reduced vitamin absorption.
  5. Continue for at least 12 weeks: If less than 5% body weight is lost, treatment should be re‑evaluated (as per NICE guidance).

🗒️ Prescribing Insight: Orlistat is not a “magic pill” – it enhances the effects of diet and exercise. Success requires adherence to both medication and lifestyle changes. NICE recommends orlistat only after dietary and exercise efforts have been tried.

Orlistat Mechanism FAQs

It still blocks fat absorption, but a high‑fat diet will cause unpleasant side effects like oily stools and spotting. For best results and tolerability, stick to a low‑fat diet.

Orlistat typically prevents the absorption of about 30% of the fat you eat. The remaining 70% is still digested and absorbed normally.

Less than 1% of an oral dose is absorbed, so systemic effects are extremely rare. It works locally inside your gut and is mostly excreted unchanged in faeces.

It can reduce absorption of fat‑soluble vitamins (A, D, E, K). That’s why doctors recommend a multivitamin supplement taken at least 2 hours apart from orlistat.

Orlistat begins working as soon as it reaches the stomach and small intestine – usually within an hour of taking it with a meal. You may notice changes in bowel habits within the first 24 hours.

Need Treatment for Weight Loss?

If you’re struggling with obesity and want to understand if orlistat could help, speak with a UK‑registered doctor through a confidential online consultation.

Secure Prescription & Next‑Day Delivery

MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | UK‑registered doctors

Start Weight Loss Consultation
Nabeel M. - Medical Content Manager at Chemist Doctor
Authored byNabeel M.

Medical Content Manager

Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.

Medical Doctor

Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.

Usman Mir - Superintendent Pharmacist
Approved byUsman Mir

Medical Director

Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.

Review Date: 23 February 2026

Next Review: 23 August 2026

Published on: 23 February 2026

Last Updated: 23 February 2026